Want to see DOC full AI Analyst Report?
DOC Stock Chart & Stats
$21.66
$0.05(0.20%)
At close: 4:00 PM EDT
$21.66
$0.05(0.20%)
Day’s Range― - ―
52-Week Range$15.70 - $22.95
Previous CloseN/A
Volume962.06K
Average Volume (3M)5.77M
Market Cap
$13.25B
Enterprise Value$25.02B
Total Cash (Recent Filing)$1.63B
Total Debt (Recent Filing)$10.32B
Price to Earnings (P/E)52.8
Beta0.47
Next Earnings
Nov 02, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend Yield6.6%
Share Statistics
EPS (TTM)0.35
Shares Outstanding689,527,300
10 Day Avg. Volume5,980,105
30 Day Avg. Volume5,774,179
Financial Highlights & Ratios
PEG Ratio-2.23
Price to Book (P/B)1.49
Price to Sales (P/S)3.97
P/FCF Ratio8.94
Enterprise Value/Market Cap1.89
Enterprise Value/Revenue8.48
Enterprise Value/Gross Profit334.86
Enterprise Value/Ebitda14.33
Forecast
1Y Price Target
$21.73Price Target Upside0.31% Upside
Rating ConsensusHold
Number of Analyst Covering13
EPS Forecast (FY)0.46
Revenue Forecast (FY)$3.01B
Bulls Say, Bears Say
Bulls Say
Balance SheetHealthpeak’s moderate leverage, substantial liquidity, and recent debt repayment provide financial flexibility through changing real-estate conditions. This supports ongoing investment, capital recycling, and selective acquisitions while reducing reliance on additional borrowing over the next several quarters.
Outpatient LeasingStrong outpatient leasing supports recurring rental income and demonstrates durable demand for Healthpeak’s healthcare-focused properties. High tenant retention, positive re-leasing spreads, and improving occupancy can sustain same-store NOI growth and strengthen portfolio cash flows.
Senior Housing GrowthJanus provides a meaningful growth engine within Healthpeak’s senior-housing platform, with strong revenue, EBITDA, and occupancy gains. Continued operating improvement can diversify earnings beyond traditional rents and increase the contribution from a debt-free, well-capitalized subsidiary.
Bears Say
Lab OccupancyLife-science properties remain less fully occupied than the outpatient portfolio, limiting near-term NOI contribution from that segment. Uncertain absorption timing could prolong vacancy costs and delay the earnings benefit of leasing activity despite an improving pipeline.
Cash Flow VolatilityPositive cash generation is being offset by a sharp decline in free-cash-flow growth and weaker conversion of earnings into operating cash. If this volatility persists, Healthpeak may have less internally generated funding for development, debt reduction, and shareholder returns.
Capital CostsHigh borrowing costs reduce the attractiveness of leverage and can constrain returns on acquisitions or redevelopment. Where vacant or older spaces require elevated capital spending, Healthpeak may face longer investment payback periods and greater execution demands before occupancy improves.
Healthpeak Properties News
DOC FAQ
What was Healthpeak Properties’s price range in the past 12 months?
Healthpeak Properties lowest stock price was $15.70 and its highest was $22.95 in the past 12 months.
What is Healthpeak Properties’s market cap?
Healthpeak Properties’s market cap is $13.25B.
When is Healthpeak Properties’s upcoming earnings report date?
Healthpeak Properties’s upcoming earnings report date is Nov 02, 2026 which is in 10 days.
How were Healthpeak Properties’s earnings last quarter?
Healthpeak Properties released its earnings results on Aug 04, 2026. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.028 by $0.052.
Is Healthpeak Properties overvalued?
According to Wall Street analysts Healthpeak Properties’s price is currently Undervalued.
Does Healthpeak Properties pay dividends?
Healthpeak Properties pays a Monthly dividend of $0.102 which represents an annual dividend yield of 6.6%. See more information on Healthpeak Properties dividends here
What is Healthpeak Properties’s EPS estimate?
Healthpeak Properties’s EPS estimate is 0.06.
How many shares outstanding does Healthpeak Properties have?
Healthpeak Properties has 689,527,300 shares outstanding.
What happened to Healthpeak Properties’s price movement after its last earnings report?
Healthpeak Properties reported an EPS of $0.08 in its last earnings report, beating expectations of $0.028. Following the earnings report the stock price went up 0.789%.
Which hedge fund is a major shareholder of Healthpeak Properties?
Currently, no hedge funds are holding shares in DOC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Healthpeak Properties Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$21.73 (0.31% Upside)
$21.73 (0.31% Upside)
Blogger Sentiment
Bullish
DOC Sentiment 80%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Decreased
By 157.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 5.9%
Last 30 Days ▲ 5.9%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.24%
12-Months-Change
Fundamentals
Return on Equity
3.30%
Trailing 12-Months
Asset Growth
9.44%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Healthpeak Properties
Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research and the provision of healthcare services.
DOC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted meaningful operational progress: strong balance sheet metrics (net debt/EBITDA 4.7x), sizable liquidity, large JV partnerships (Brookfield/Blackstone) that raise $1B+ in proceeds while preserving control, strong outpatient leasing (1.2M SF in Q2; occupancy to 90.7%), lab leasing momentum and occupancy improvement (78.5%, +140 bps YTD), and significant senior housing/Janus performance (45% revenue growth, 34% adjusted EBITDA growth). Challenges remain, notably lab occupancy still below peak, selective elevated CapEx needs for redevelopments, elevated borrowing costs limiting leverage options, cautious tenant timelines, and only a modest FFO guidance raise. Overall the positive operational momentum, strategic partnerships, and strong liquidity and balance sheet outweigh the remaining execution and market risks.View all DOC earnings summariesDOC Revenue Breakdown
76.41% Rental and related revenues
21.40% Resident fees and services
2.19% Interest income and other

DOC Stock 12 Month Forecast
Average Price Target
$21.73
▲(0.31% Upside)
Technical Analysis
Omega Healthcare
―
Sabra Healthcare REIT
―
Medical Properties Trust
―
Healthcare Realty Trust
―
National Healthcare Properties
―
Ownership Overview
0.24% Insiders
29.10% Mutual Funds
1.18% Other Institutional Investors
33.98% Public Companies and
Individual Investors










